-+ 0.00%
-+ 0.00%
-+ 0.00%

*Erasca Focuses on Developing Therapies for Patients With RAS/MAPK Pathway-Driven Cancers >ERAS

Dow Jones·07/14/2026 03:22:00

Please log in to view news